EUVIMEDEUVIMED entdecken
Leserbrief

Bicontinuous Nanoparticles from Spontaneous Self-Assembly of Block Copolymer Prodrug in Aqueous Medium for Potential Cancer Therapy

Juthi Pal iD, Pousali Samanta, Afruja Khan, Rishabh Maity, Amirul Islam Mallick iD, Dibakar Dhara iD

ACS Macro Letters · 2025

DOI: 10.1021/acsmacrolett.4c00590 ↗

Kurz gefasst

Leserbrief in der Zeitschrift ACS Macro Letters, 2025. Verfasst von Juthi Pal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Indian Institute of Technology Kharagpur, Kharagpur, West Bengal 721302, India. Hauptthemen laut MEDLINE: Prodrugs, Doxorubicin, Nanoparticles, Polymers. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: University Grants Commission, Science and Engineering Research Board, Indian Institute of Technology Kharagpur.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite having several advantages, bicontinuously structured polymeric nanoparticles (BSPNPs) are far less explored in the field of controlled drug delivery owing to the requirement of complex precursor copolymers and the associated multistep synthetic procedures. In this work, we report the synthesis of a redox-sensitive diblock copolymer (P1), which was subsequently utilized to prepare doxorubicin (DOX) containing a pH-labile prodrug (P2). P1 and P2 spontaneously self-assembled in aqueous media above their critical aggregation concentration, forming micellar nanoparticles with rare bicontinuous morphology that promotes loading of both hydrophobic and hydrophilic cargoes in different compartments. To the best of our knowledge, the formation of BSPNPs through direct self-assembly in aqueous media has not yet been reported. In vitro cellular studies asserted the higher safety profile of the nanoparticles against noncancerous cells (HEK293T) than free DOX, whereas they displayed higher drug-induced cytotoxicity against cancer cells (MCF-7) in comparison to free DOX, establishing them as promising cancer drug delivery systems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsDoxorubicinNanoparticlesPolymersAntineoplastic AgentsHumansMCF-7 CellsHEK293 CellsMicellesWaterHydrophobic and Hydrophilic InteractionsDrug Delivery SystemsCell SurvivalDrug CarriersHydrogen-Ion ConcentrationAntibiotics, Antineoplastic

Substanzen

ProdrugsDoxorubicinPolymersMicellesWaterAntineoplastic AgentsDrug CarriersAntibiotics, Antineoplastic

Autor:innen und Institutionen

  • Department of Chemistry, Indian Institute of Technology Kharagpur, Kharagpur, West Bengal 721302, India.
  • Department of Biological Sciences, Indian Institute of Science Education and Research Kolkata, Mohanpur, Nadia, West Bengal 741 246, India.

ORCID-Profile: Juthi Pal, Amirul Islam Mallick, Dibakar Dhara

Förderung

  • University Grants Commission
  • Science and Engineering Research Board
  • Indian Institute of Technology Kharagpur
  • Ministry of Education, India
  • Indian Institute of Science Education and Research Kolkata
  • Academic and Research Fund
  • Anusandhan National Research Foundation

Zitieren

APA

Pal, J., Samanta, P., Khan, A., Maity, R., Mallick, A. I., & Dhara, D. (2025). Bicontinuous Nanoparticles from Spontaneous Self-Assembly of Block Copolymer Prodrug in Aqueous Medium for Potential Cancer Therapy. ACS Macro Letters. https://doi.org/10.1021/acsmacrolett.4c00590

Vancouver

Pal J, Samanta P, Khan A, Maity R, Mallick AI, Dhara D. Bicontinuous Nanoparticles from Spontaneous Self-Assembly of Block Copolymer Prodrug in Aqueous Medium for Potential Cancer Therapy. ACS Macro Letters. 2025. doi:10.1021/acsmacrolett.4c00590

BibTeX
@article{Pal2025,
  author = {Pal, Juthi and Samanta, Pousali and Khan, Afruja and Maity, Rishabh and Mallick, Amirul Islam and Dhara, Dibakar},
  title = {Bicontinuous Nanoparticles from Spontaneous Self-Assembly of Block Copolymer Prodrug in Aqueous Medium for Potential Cancer Therapy},
  journal = {ACS Macro Letters},
  year = {2025},
  doi = {10.1021/acsmacrolett.4c00590}
}
Kostenlos starten →